Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 2003, p. 4594-4599, Vol. 41, No. 10
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.10.4594-4599.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Jung-Yun Hong,1 Hoan-Jong Lee,1* Seon-Hee Shin,1,
Yun-Kyung Kim,1 Toshiki Inada,2 Madoka Hashido,2 and Pedro A. Piedra3
Department of Pediatrics, College of Medicine, Seoul National University, Seoul, Korea,1 Infectious Diseases Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan,2 Department of Molecular Virology and Microbiology and Department of Pediatrics, Baylor College of Medicine, Houston, Texas3
Received 3 April 2003/ Returned for modification 4 June 2003/ Accepted 15 July 2003
|
|
|---|
|
|
|---|
Most adenovirus LRTIs are mild and indistinguishable from LRTIs caused by other respiratory viruses. However, adenoviruses can cause severe, often fatal pneumonia or bronchiolitis. Severe acute respiratory illness has been noted in association with Ad1 through Ad8, Ad19, Ad21, Ad35, and others, but outbreaks of severe infections in healthy children are most frequently reported with Ad7, followed by Ad3 and Ad21 (11, 16, 20, 29). Epidemics of severe acute respiratory illness caused by these adenovirus types have often been noted among infants of Asian descent and native populations in New Zealand, Canada, and northern Finland. It is unknown whether this severe form of respiratory illness in those populations is attributable to genetic differences, environmental factors such as socioeconomic status, crowding in a cold climate, or the virulence of viral strains.
Different genomic DNA patterns within each serotype can be identified by restriction enzyme analysis. These different restriction patterns have been designated genome types (31, 34). Genome types may vary by location and time of isolation and may be useful markers for epidemiological studies (1-3, 6-9, 15, 16, 18-22, 24, 27, 29-34). It has been suggested that some genome types may be associated with greater virulence (15, 16, 34). Therefore, analysis of genome types is of clinical as well as epidemiological importance.
Different systems used to classify or denominate genome types have been proposed. Among these, the system proposed by Li and Wadell (19) and subsequently modified by Li et al. (20) has been widely used. In their nomenclature system, the prototype strain is abbreviated "p," and strains that have the same serotype but that have different BamHI patterns are designated "a," "b," "c," and so forth. An Arabic numeral is added after "p," "a," "b," "c," and so forth to describe the different genome types distinguished by use of additional restriction endonucleases (e.g., Ad3p, Ad3p1, Ad3a, Ad3a5, and Ad7d2). Genome types of Ad3 that have been identified to date are 3p, the prototype and 3a through 3x and their variants. Genome types of Ad7 that have been identified are 7p and 7a through 7k and their variants.
The genomic diversity of adenoviruses has been a subject of many publications. To our knowledge, however, there have been limited reports on the genome types of Ad3 and Ad7 in successive outbreaks over an extended observation period in the same geographic region. In Korea, successive outbreaks of severe acute respiratory illnesses caused by Ad3 and Ad7 infections in children were recognized during the 1990s (11). This study was performed to characterize the genome types of Ad3 and Ad7 strains isolated during these successive outbreaks and to investigate the possible relationship between genome type and clinical severity of illness.
|
|
|---|
Clinical records of children hospitalized at the Seoul National University Children's Hospital were reviewed (11).
Specimens. Nasal aspirate specimens were collected by using mucus traps and catheters. The specimens were refrigerated immediately after collection and processed in the laboratory within 48 h (11, 36).
Viral antigen detection. Indirect immunofluorescence staining for adenovirus was done directly on nasal aspirate specimens by using murine monoclonal antibodies (Chemicon, Temecula, Calif.) and fluorescein isothiocyanate-conjugated rabbit antimurine immunoglobulin G (Cappel, West Chester, Pa.) (11, 36).
Viral culturing and identification. Nasal aspirate specimens were also inoculated into HEp-2, MDCK, and LLC-MK2 culture tubes (11, 36). The culture tubes were observed for 3 to 4 weeks for cytopathic effect or hemadsorption, and viral identification was confirmed by a virus-specific indirect immunofluorescence test.
Serotyping of adenoviruses.
Adenovirus serotypes were identified by a neutralization assay with type-specific reference antisera (10, 11, 17, 25). Serotyping was performed to identify the common serotypes in children, Ad1 to Ad7 and Ad11, which account for
85% of all adenovirus infections in children.
Preparation of viral DNA. Ad3 and Ad7 strains that had been stored at -70°C were subsequently propagated on HEp-2 cells in 100-mm petri dishes. Infected cells were incubated in 2% Eagle's minimal essential medium until extensive adenovirus cytopathic effect was evident, usually at 3 to 4 days. Viral DNA was extracted from the infected cell lysates by using a modified Hirt procedure (28).
DNA restriction analysis. Twelve restriction enzymes that recognized 6 bp were used (BamHI, BclI, BglI, BglII, BstEII, EcoRI, HindIII, HpaI, SalI, SmaI, XbaI, and XhoI; purchased from KOSCO Central Research Institute, Seoul, Korea, and New England Biolabs, Beverly, Mass.). Aliquots of 0.5 to 1 µg of DNA were digested with 5 to 10 U of each of the above endonucleases according to the manufacturers' instructions. DNA fragments were separated by electrophoresis in 0.8 or 1.0% agarose gels (Sigma Chemical Co., St. Louis, Mo.), which were prepared and run in 0.5x-concentrated Tris buffer (40 mM Tris-acetate buffer, 2 mM EDTA [pH 8.3]) at 35 V for 8 h. Bands were stained with ethidium bromide (0.1 µg/ml) and visualized by using an image analyzer (Bioimage processing system 3.0; Biomedlab Co., Seoul, Korea) or photographed on a transilluminator (Seoulin Scientific Co., Ltd., Seoul, Korea) by using a Polaroid camera (Polaroid Corporation, Cambridge, Mass.).
Nomenclature of genome types. Genome type assignments were made by comparing the resulting restriction profiles with the restriction patterns of prototype and other genome types described in the literature and by following the genome type denomination system (8, 18-20, 30).
Phylogenetic analysis. Analysis of genetic relatedness between genome types was performed by using Bio-profill image analysis software (Bio-1D ++, version 99; Vilber Lourmat Biotechnology, Marne la Vallée, France).
|
|
|---|
(ii) Outbreaks of Ad3 and Ad7. During the observation period, two outbreaks each of Ad3 and Ad7 were identified (Fig. 1 and 2). Ad3 activity was detected from September 1991 to January 1995. Subsequently, there was an explosive epidemic of Ad7 from September 1995 to November 1997 (11). From June 1998 to April 1999, there was another smaller epidemic of Ad7 that was succeeded by an Ad3 epidemic from September 1998 to November 1999.
![]() View larger version (18K): [in a new window] |
FIG. 1. Temporal distributions of genome types of Ad3 isolated at Seoul National University Children's Hospital from November 1990 to July 2000. Note that the time frame for each bar represent a 2-month period. From left to right, months are shown as follows: N, November; J, January; M, March; M, May; J, July; and S, September.
|
![]() View larger version (14K): [in a new window] |
FIG. 2. Temporal distributions of genome types of Ad7 isolated at Seoul National University Children's Hospital from November 1990 to July 2000. Time frames and months are as described in the legend to Fig. 1. The number of Ad7 isolates during May-June 1996 was 44.
|
(i) Ad3. All 56 Ad3 strains appeared identical to the Ad3a reference strain when digested with BamHI, BclI, BstEII, SalI, EcoRI, and HindIII, but analyses with BglI, BglII, SmaI, and XbaI distinguished Ad3a from the novel genome types.
Digestion patterns with BglI, BglII, SmaI, and XbaI are shown in Fig. 3. Digestion with BglI yielded three patterns (I to III). Pattern I was identical to that of the previously described Ad3a genome type (19), while the other two patterns (II and III) were novel. Digestion with BglII produced two patterns. Pattern I was identical to that of the Ad3a reference strain (19). Digestion with SmaI revealed three patterns. Pattern I was identical to that of the Ad3a reference strain (19). Patterns II and III were novel. Digestion with XbaI revealed two patterns. Pattern I was identical to that of the Ad3a reference strain (19). Pattern II was identical to that of Ad3d and Ad3-7 (19).
![]() View larger version (45K): [in a new window] |
FIG. 3. Restriction fragment analysis of DNAs of Ad3 (four left panels) and Ad7 (one right panel). Viral DNAs were digested with the indicated enzymes and separated by 0.8% agarose electrophoresis. Lanes M, DNA molecular size markers.
|
|
View this table: [in a new window] |
TABLE 1. Combinations of restriction fragment patterns produced by four enzymes used to identify genome types of Ad3
|
Analysis of relatedness among genome types. (i) Ad3. All of the Ad3 genome types were closely related and shared 91 to 99% pairwise comigrating restriction fragments (PCRFs) (Fig. 4). Ad3a13 was closely related to Ad3a15 and Ad3a16, by 98 and 99% PCRFs, respectively. Ad3a14 and Ad3a17 were also closely related, by 98% PCRFs.
![]() View larger version (10K): [in a new window] |
FIG. 4. Phylogenetic trees of eight genome types of Ad3 and five genome types of Ad7 according to relatedness defined as percent pairwise comigrating restriction fragments.
|
Temporal distributions of Ad3 and Ad7 genome types. The temporal distributions of the Ad3 genome types are shown in Fig. 1. Some genome types were identified in both of the Ad3 outbreaks, while others were identified only in one outbreak. In the first Ad3 outbreak, genome types Ad3a, Ad3a13, Ad3a14, and Ad3a15 were isolated. In the second Ad3 outbreak, six genome types, Ad3a, Ad3a13, Ad3a14, Ad3a16, Ad3a17, and Ad3a18, cocirculated. One of the more common genome types (Ad3a15) isolated in the first Ad3 outbreak was not identified in the second outbreak. Some of the genome types (Ad3a, Ad3a13, and Ad3a14) were common in both outbreaks, while most of the strains in the second Ad3 outbreak belonged to genome types (Ad3a16, Ad3a17, and Ad3a18) that were not previously identified.
The temporal distributions of the Ad7 genome types are shown in Fig. 2. A large outbreak of Ad7d began in October 1995, peaked in May to June 1996, and ended at the end of 1996. This outbreak was followed by smaller epidemics of Ad7d and Ad7l in 1998. Ad7l was the predominant genome type during the second outbreak.
Clinical outcomes. The medical records of 28 of 31 children who had Ad3 and 50 of 51 children who had Ad7 and who were admitted to the Seoul National University Children's Hospital were reviewed. The medical records of four children were not available. The medical records of the 110 children admitted to other hospitals throughout Korea were not reviewed. Twenty-seven of 28 Ad3-infected children recovered, and 1 child infected with Ad3a13 died. The fatality rate for the Ad3 genome type was 3.6%. Forty-one children infected with Ad7 recovered (32 patients with Ad7d and 9 patients with Ad7l), and 9 children died (7 patients with Ad7d and 2 patients with Ad7l). The fatality rate for both Ad7 genome types was 18%.
|
|
|---|
All of the Ad3 isolates showed restriction band patterns identical to that of Ad3a with BamHI, BclI, BstEII, EcoRI, HindIII, HpaI, SalI, and XhoI. The combination of restriction fragment patterns produced by SmaI, BglI, BglII, and XbaI yielded seven Ad3a genome types. In contrast to the rather high genetic heterogeneity of Ad3, 98 strains of Ad7 were classified into two genome types by BamHI and the other restriction endonucleases.
Genome types of Ad3 identified in the literature are Ad3p, the prototype strain, and Ad3a through Ad3x, along with their variants (15). The Ad3a variants that have been described are Ad3a1 through Ad3a12 (8, 19, 20, 30). In China, the dominant genome type of Ad3 was Ad3a2, with occasional isolates of Ad3a4, Ad3a5, and Ad3a6, from 1962 to 1988 (20); in Japan, the dominant genome type was Ad3a, with occasional isolates of Ad3a8 and Ad3c, from 1983 to 1991 (12, 21). In this study, we identified six new variants of Ad3a, Ad3a13 through Ad3a18.
In contrast to Ad3 genome types, the worldwide epidemiology of Ad7 is relatively well delineated. Both globally dispersed and geographically restricted Ad7 genome types were identified by restriction analysis, and regional shifts or replacements of dominant genome types were documented on different continents.
During the last two decades, changes in the dominant genome types of Ad7 were observed in many parts of the world. In South America, a shift from Ad7c to Ad7h occurred in 1986 (14), and Ad7h subsequently caused serious acute respiratory illnesses in infants and young children in Chile and Argentina (15). In the early 1980s in China, a new genome type, Ad7d (32), replaced Ad7b as the predominant circulating virus. Ad7d2 has emerged as the predominant virus circulating in Israel since 1992 (2). Recent reports demonstrated that Ad7d, Ad7d2, and Ad7h have spread beyond their formerly geographically restricted regions. Ad7d2 and Ad7h have been identified in the United States, where the dominant genome type has been Ad7b (5). Twenty-two Ad7 strains isolated from 1987 to 1992 in Japan were Ad7d (22), and a recent countrywide epidemic of Ad7 in Japan during the period from 1995 to 1998 was attributed to Ad7d2 (23, 35). Ad7h also has been recognized in Japan (9).
In Korea, there was a large epidemic of Ad7d from 1995 to 1997, and it was followed by a smaller epidemic of Ad7d and Ad7l in 1998 to 1999. A change in genome types from Ad7d to Ad7l was observed during these two Ad7 epidemics. It is interesting that Korea had an Ad7d outbreak after two neighboring countries, China and Japan, had Ad7d epidemics (20, 22). It should also be noted that both Korea and Japan recently had Ad7 epidemics during a similar time period; however, the genome types were not identical. The Korean strains of Ad7d and Ad7l and the Japanese strain of Ad7d2 were closely related, with 99% PCRFs for Ad7d and Ad7d2 and 96% PCRFs for Ad7d2 and Ad7l (Fig. 4).
During epidemics, several variant genome types of the same serotype frequently cocirculate, especially when an epidemic involves a large population, and an outbreak in a closed community may be caused by a single genome type (24). Heterogeneity of genome types in a single epidemic is more common for Ad3, as seen in this study, but may also be observed for Ad7 (20, 24). During the epidemic of viral pneumonia in China in 1958, four genome types of Ad7 were isolated from lung specimens obtained at autopsy, and during a 1983 Ad3 outbreak in Beijing, three genome types, Ad3a2, Ad3a4, and Ad3a5, were isolated in 1 month (20). Most of the genome types within a serotype were closely related, suggesting that the variants might have been the result of genetic drift from an epidemic genome type.
Although many studies have described the genetic heterogeneity of adenoviruses, only a few studies have examined changes in genome types in successive outbreaks of Ad3 and Ad7. Mizuta et al. (21) examined Ad3 genome types isolated in successive outbreaks. The Ad3 isolates were mixtures of three genome types, which had all appeared several months before the epidemics. They concluded that the outbreaks were not due to the appearance of a new genome type. However, they used only four restriction endonucleases and therefore encountered limitations in the discrimination of the genome types. In the report of Itakura et al., the genome types of Ad3 isolated during two consecutive epidemics of keratoconjunctivitis were different (12). Itoh et al. suggested that the emergence of new Ad3 genome types may contribute to the replacement of prior adenovirus serotypes associated with conjunctivitis (13). The nationwide epidemic of Ad7 in Japan in 1995 to 1998 occurred with the emergence of Ad7d2 in a setting of low-grade activity of Ad7d during the preceding years (23).
The first nationwide epidemic of Ad7 in Korea described in this study was also associated with the appearance of Ad7d, and the dominant genome type of the subsequent Ad7 epidemic 2 years later was Ad7l. Also, in this study, most of the Ad3 strains in the second epidemic were new genome types. The clinical significance of the emergence of new genome types is not clear at the moment. While some genome types are claimed to be associated with higher virulence (15, 16, 34), differences in fatality rates according to genome types could not be demonstrated in this study. However, the dominance of new genome types in each of the second outbreaks of Ad3 and Ad7 described in this study suggests that changes in genome types may contribute to the occurrence of an epidemic. This suggestion is consistent with the conclusions of Noda et al. (23) but in contrast to the suggestion by Mizuta et al. (21) that outbreaks of Ad3 were due to endemic genome types rather than new types.
In summary, we have described the molecular epidemiology of Ad3 and Ad7 outbreaks in Korea over 11 consecutive years from 1990 to 2000. We characterized seven Ad3 genome types (Ad3a, Ad3a13, Ad3a14, Ad3a15, Ad3a16, Ad3a17, and Ad3a18) and two Ad7 genome types (Ad7d and Ad7l), among which six genome types of Ad3 (Ad3a13, Ad3a14, Ad3a15, Ad3a16, Ad3a17, and Ad3a18) and one genome type of Ad7 (Ad7l) were novel. Minor changes in genomic sequences may be sufficient to exert a survival advantage over prior circulating genome types. However, we saw no evidence that these minor changes resulted in different disease severities, as case fatality rates for Ad7d and Ad7l infections were both 18%.
We are grateful to Kyung Hye Moon for excellent technical support.
Present address: Helminth Immunology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20852. ![]()
Present address: Department of Pediatrics, College of Medicine, Hallym University, Seoul, Korea. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»